Approximately 30% of high-grade dysplastic nodules demonstrate decreased expression of these transporters; the percentage rises to 70% in early HCC, while all poorly-differentiated tumors show decreased or absent expression of OATP transporters [153], leading to low signal intensity on the hepatobiliary phase. Here, SLCO1A2 is linked to hepatocellular carcinoma.